Nathalie M. Goemans
Department Of Rehabilitation Sciences
Leuven, VLG, Belgium
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 109 publications
Balancing Benefits and Risks: Long-term Use of Daily versus Intermittent Corticosteroids in Duchenne Muscular Dystrophy.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 02, 2026
Descriptive characterization of ambulatory health states in Duchenne muscular dystrophy: Motor function trajectories and times to loss of ambulation.
Journal: Journal of neuromuscular diseases
Published: September 23, 2025
Re-evaluating acceptable risk of death from gene therapy: A threshold study among individuals with Duchenne muscular dystrophy and their caregivers in the US and UK.
Journal: European journal of medical genetics
Published: May 15, 2025
Longitudinal interaction between muscle impairments and gait pathology in growing children with Duchenne muscular dystrophy.
Journal: Journal of neuroengineering and rehabilitation
Published: March 23, 2025
Development of the accredited duchenne centers program, a global program to achieve uniform and up-to-date care for all people living with duchenne muscular dystrophy.
Journal: Orphanet journal of rare diseases
Published: March 10, 2025
Muscle weakness but also contractures contribute to the progressive gait pathology in children with Duchenne muscular dystrophy: a simulation study.
Journal: Journal of neuroengineering and rehabilitation
Published: November 28, 2024
Genotype and corticosteroid treatment are distinctively associated with gray matter characteristics in patients with Duchenne muscular dystrophy.
Journal: Neuromuscular disorders : NMD
Published: August 05, 2024
Longitudinal trajectories of muscle impairments in growing boys with Duchenne muscular dystrophy.
Journal: PloS one
Published: June 27, 2024
Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpoint.
Journal: Scientific reports
Published: May 24, 2024
Development and Pilot Validation of the DuMAND Checklist to Screen for Duchenne Muscular Dystrophy-Associated Neurobehavioral Difficulties (DuMAND).
Journal: Journal of neuromuscular diseases
Published: May 10, 2024
Last Updated: 09/26/2026